{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T13:56:24Z","timestamp":1778162184752,"version":"3.51.4"},"reference-count":14,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Medicine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.clinme.2025.100502","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T15:18:04Z","timestamp":1755011884000},"page":"100502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Perioperative prevention of euglycaemic diabetic ketoacidosis in people living with type 2 diabetes established on sodium-glucose transport-2 inhibitors \u2013 a cross-site multi-cycle audit"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3383-0942","authenticated-orcid":false,"given":"Karl A.","family":"Romain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jody","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Ho Luka","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6404-9493","authenticated-orcid":false,"given":"Kenneth","family":"Watters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aikaterini","family":"Theodoraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinme.2025.100502_bib0001","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Me"},{"key":"10.1016\/j.clinme.2025.100502_bib0002","doi-asserted-by":"crossref","unstructured":"Dennis JM Henley WE McGovern AP et al. Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: a retrospective analysis of primary care data, 2010\u20132017. Diabetes, Obes Metab. 2019 21 1576\u20131584 doi:10.1111\/dom.13687.","DOI":"10.1111\/dom.13687"},{"key":"10.1016\/j.clinme.2025.100502_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2021.777861","article-title":"Sodium-glucose cotransporter 2 inhibitors mechanisms of action: a review","volume":"8","author":"Fonseca-Correa","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.clinme.2025.100502_bib0004","first-page":"13","article-title":"Euglycemic diabetic ketoacidosis and sodium-glucose cotransporter-2 inhibitors: a focused review of pathophysiology, risk factors, and triggers","author":"Somagutta","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.clinme.2025.100502_bib0005","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.eprac.2022.06.006","article-title":"Inpatient perioperative euglycemic diabetic ketoacidosis due to sodium-glucose cotransporter-2 inhibitors \u2013 lessons from a case series and strategies to decrease incidence","volume":"28","author":"Mehta","year":"2022","journal-title":"Endocr Pract"},{"key":"10.1016\/j.clinme.2025.100502_bib0006","series-title":"Guideline for perioperative care for people with diabetes mellitus undergoing elective and emergency surgery","isbn-type":"print","author":"Ayman","year":"2021","ISBN":"https:\/\/id.crossref.org\/isbn\/9781900936255"},{"key":"10.1016\/j.clinme.2025.100502_bib0007","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ajem.2021.02.015","article-title":"Euglycemic diabetic ketoacidosis: etiologies, evaluation, and management","volume":"44","author":"Long","year":"2021","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.clinme.2025.100502_bib0008","unstructured":"Signorell A DescTools: tools for descriptive statistics. 2025. Available from: https:\/\/cran.r-project.org\/package=DescTools (Accessed August 19, 2025)."},{"key":"10.1016\/j.clinme.2025.100502_bib0009","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.bja.2024.01.011","article-title":"Dose-dependent relationship between SGLT2 inhibitor hold time and risk for postoperative anion gap acidosis. Comment on <em>Br J Anaesth<\/em>2023; 131: 682\u2013686","volume":"132","author":"Heijne","year":"2024","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.clinme.2025.100502_bib0010","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.bja.2023.06.063","article-title":"Dose-dependent relationship between SGLT2 inhibitor hold time and risk for postoperative anion gap acidosis: a single-centre retrospective analysis","volume":"131","author":"Steinhorn","year":"2023","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.clinme.2025.100502_bib0011","first-page":"10","article-title":"Dehydration and insulinopenia are necessary and sufficient for euglycemic ketoacidosis in SGLT2 inhibitor-treated rats","author":"Perry","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.clinme.2025.100502_bib0012","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00540-024-03335-3","article-title":"Incidence of sodium-glucose cotransporter-2 inhibitor-associated perioperative ketoacidosis in surgical patients: a prospective cohort study","volume":"38","author":"Seki","year":"2024","journal-title":"J Anesth."},{"key":"10.1016\/j.clinme.2025.100502_bib0013","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.bja.2023.12.015","article-title":"Perioperative use of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors for diabetes mellitus","volume":"132","author":"Dhatariya","year":"2024","journal-title":"Br J Anaesth."},{"key":"10.1016\/j.clinme.2025.100502_bib0014","unstructured":"FDA Drug Safety FDA revises labels of SGLT2 inhibitors for diabetes to include warnings about too much acid in the blood and serious urinary tract infections available online: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-revises-labels-sglt2-inhibitors-diabetes-include-warnings-about-too-much-acid-blood-and-serious (Accessed 25 May 2015)."}],"container-title":["Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211825002209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211825002209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:17:21Z","timestamp":1762546641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470211825002209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1470211825002209"],"URL":"https:\/\/doi.org\/10.1016\/j.clinme.2025.100502","relation":{},"ISSN":["1470-2118"],"issn-type":[{"value":"1470-2118","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perioperative prevention of euglycaemic diabetic ketoacidosis in people living with type 2 diabetes established on sodium-glucose transport-2 inhibitors \u2013 a cross-site multi-cycle audit","name":"articletitle","label":"Article Title"},{"value":"Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinme.2025.100502","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of Royal College of Physicians.","name":"copyright","label":"Copyright"}],"article-number":"100502"}}